期刊文献+

离子敏感鼻用原位凝胶的制备及其兔消除动力学 被引量:17

Preparation of Ion-Activated in Situ Gel Systems for Nasal Use and Its Elimination Pharmacokinetic Study in Rabbits
下载PDF
导出
摘要 目的制备离子敏感型鼻用原位凝胶剂,研究其在家兔鼻腔内的在体消除动力学。方法采用去乙酰结冷胶为材料制备离子敏感型原位凝胶。考察原位凝胶的微观结构、流变性、持水能力,以99mTc-DTPA为示踪剂用γ-闪烁照相技术评价原位凝胶在家兔鼻腔中的滞留时间,计算其消除动力学参数。结果0.5%去乙酰结冷胶可制备原位凝胶,其微观结构是由阳离子与去乙酰结冷胶链上的羰基络合形成的双螺旋结构逆向聚集而成的三维网络结构。原位凝胶可明显提高药物在鼻腔内的滞留时间,其AUC0-t和AUC0-∞分别是对照制剂的2和7倍。结论应用0.5%去乙酰结冷胶可成功制备离子敏感型鼻用原位凝胶,其在鼻腔中的滞留时间有较显著的延长。 OBJECTIVE To prepare ion-sensitivity in situ gels and investigate its elimination pharmacokinetics in rabbits. METHODS Gels with deacetylated gellan gum (DGG) were prepared. Mierostructure of gels was studied by optical microscope. The rheology and the water holding capacity of gels were investigated by viscosity and centrifugal experiement. ^99mTc-DTPA was used as model drug to investigate the nasal residence time. RESULTS The microstructure of gels was formed by the aggregation of the double helical segments to form a three-dimensional network. The use of polymer such as 0. 5% deacetylated gellan gum in nasal dosage forms increased the residence time within the nasal cavity and provided the opportunity for sustained nasal drug delivery. CONCLUSION The gels with 0. 5% deacetylated gellan gum are prepared successfully.
出处 《中国药学杂志》 CAS CSCD 北大核心 2007年第11期844-848,共5页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(30171112)
关键词 去乙酰结冷胶 离子敏感原位凝胶 持水性 消除动力学 deacetylated gellan gum ion-activited in sita gel water holding capacity elimination pharmacokinetic
  • 相关文献

参考文献14

  • 1Lu B..New Technigues and New Dosage Forms of Drugs(药物新剂型与新技术)[M]..People's Medical Publishing House,,2002..451-463..
  • 2DESAI S D,BLANCHARD J.Evaluation of pluronic F127 sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model[J].Pharm Sci,1998,87(10):1190-1195.
  • 3BOCHOT A,FATTAL E,GULIK A,et al.Liposomes dispersed within a thermosensitive gel:a new dosage form for ocular delivery of oligonucleotides[J].Pharm Res,1998,15(9):1364-1369.
  • 4COHEN S,LOBEL E,TREVGODA A,et al.A novel in ituforming ophthalmic drug delivery system from alginates ndergoing gelation in the eye[J].J Controlled Release,1997.44(2-3):201-208.
  • 5SRIVIDYA B,CARDOZA R M,AMIN P D.Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system[J].J Controlled Release,2001,73(2-3):205-211.
  • 6CARFORS J,EDSMAN K,PETERSSON R,et al.Rheological evaluation of Gelrite in situ gels for ophthalmic use[J].Eur J Pharm Sci,1998,6(2):113-119.
  • 7KUBO W,MIYAZAKI S,ATTWOOD D.Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations[J].Int J Pharm,2003,258(1-2):55-64.
  • 8MIYAZAKI S,KAWASAKI N,KUBO W.Comparison of in situ gelling formulations for the oral delivery of cimetidine[J].Int J Pharm,2001,220(1-2):161-168.
  • 9LINDELL K,ENGSTROM S.In vitro release of timolol maleate from an in situ gelling polymer system[J].Int J Pharm,1993,95(1-3):219-228.
  • 10ROZIER A,MAZUEL C,GROVE J.Functionality testing of gellan gum,a polymeric excipient material for ophthalmic dosage forms[J].Int J Pharm,1997,153(2):191-198.

同被引文献178

引证文献17

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部